Annual Current Liabilities
$10.17 M
+$2.37 M+30.46%
December 31, 2023
Summary
- As of February 10, 2025, CGTX annual total current liabilities is $10.17 million, with the most recent change of +$2.37 million (+30.46%) on December 31, 2023.
- During the last 3 years, CGTX annual current liabilities has risen by +$6.92 million (+212.89%).
- CGTX annual current liabilities is now at all-time high.
Performance
CGTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$12.71 M
+$1.78 M+16.35%
September 30, 2024
Summary
- As of February 10, 2025, CGTX quarterly total current liabilities is $12.71 million, with the most recent change of +$1.78 million (+16.35%) on September 30, 2024.
- Over the past year, CGTX quarterly current liabilities has increased by +$4.48 million (+54.39%).
- CGTX quarterly current liabilities is now at all-time high.
Performance
CGTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CGTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.5% | +54.4% |
| 3 y3 years | +212.9% | +54.4% |
| 5 y5 years | +176.1% | +54.4% |
CGTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.5% | at high | +86.3% |
| 5 y | 5-year | at high | +212.9% | at high | +290.9% |
| alltime | all time | at high | +212.9% | at high | +290.9% |
Cognition Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.71 M(+16.3%) |
| Jun 2024 | - | $10.92 M(+14.9%) |
| Mar 2024 | - | $9.50 M(-6.5%) |
| Dec 2023 | $10.17 M(+30.5%) | $10.17 M(+23.6%) |
| Sep 2023 | - | $8.23 M(+4.0%) |
| Jun 2023 | - | $7.91 M(+6.0%) |
| Mar 2023 | - | $7.46 M(-4.2%) |
| Dec 2022 | $7.79 M | $7.79 M(-35.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $12.12 M(+77.7%) |
| Jun 2022 | - | $6.82 M(-10.8%) |
| Mar 2022 | - | $7.64 M(-2.8%) |
| Dec 2021 | $7.86 M(+142.0%) | $7.86 M(+77.6%) |
| Sep 2021 | - | $4.43 M(-28.9%) |
| Jun 2021 | - | $6.22 M(+43.5%) |
| Mar 2021 | - | $4.34 M(+33.5%) |
| Dec 2020 | $3.25 M(-11.8%) | $3.25 M |
| Dec 2019 | $3.68 M | - |
FAQ
- What is Cognition Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Cognition Therapeutics?
- What is Cognition Therapeutics annual current liabilities year-on-year change?
- What is Cognition Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cognition Therapeutics?
- What is Cognition Therapeutics quarterly current liabilities year-on-year change?
What is Cognition Therapeutics annual total current liabilities?
The current annual current liabilities of CGTX is $10.17 M
What is the all time high annual current liabilities for Cognition Therapeutics?
Cognition Therapeutics all-time high annual total current liabilities is $10.17 M
What is Cognition Therapeutics annual current liabilities year-on-year change?
Over the past year, CGTX annual total current liabilities has changed by +$2.37 M (+30.46%)
What is Cognition Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of CGTX is $12.71 M
What is the all time high quarterly current liabilities for Cognition Therapeutics?
Cognition Therapeutics all-time high quarterly total current liabilities is $12.71 M
What is Cognition Therapeutics quarterly current liabilities year-on-year change?
Over the past year, CGTX quarterly total current liabilities has changed by +$4.48 M (+54.39%)